Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT05085028

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Royal Bournemouth Hospital Bournemouth, United Kingdom

Royal Sussex County Hospital Brighton, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Queen's Hospital Burton-on-Trent, United Kingdom

View all 37 locations

View Trial Details

Recruiting

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT05377658

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

NCT05965024

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

NCT05930665

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

NCT06241807

Conditions: Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

A Phase IIII Study of AL8326 in Small Cell Lung Cancer

NCT06247605

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: JILIN Cancer Hospital Changchun, Jilin, China

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore

NCT06232265

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

NCT05969041

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +39 more
Locations: St Vincent's Public Hospital Sydney Darlinghurst, New South Wales, Australia

Scientia Clinical Research Ltd Randwick, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Souther Oncology Clinical Research Unit (SOCRU) Bedford Park, South Australia, Australia

View Trial Details

Recruiting

Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC

NCT05011487

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions